Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal

Article Article scientifique Lettre Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal eng 2011 author Fontanet Aline 595495 author Chalandon Yves 0000-0001-9341-8104 644957 author Roosnek Eddy Emile 27236 author Mohty Bilal 727819 author Passweg Jakob 632725 1272-1273 10.1038/bmt.2010.285 21102496 0268-3369 Adolescent Adult Aged Anti-Infective Agents/adverse effects/therapeutic use Blood Platelets/physiology Case-Control Studies Female Hematologic Diseases/blood/surgery Hematopoietic Stem Cell Transplantation Humans Male Middle Aged Neutrophils/physiology Trimethoprim-Sulfamethoxazole Combination/adverse effects/therapeutic use Young Adult Dewey 616 Swiss National Science Foundation T cell and NK-cell immunity after hematopoietic stem cell transplantation and under inflammatory/anti-inflammatory conditions 127516 CH Project funding 56 Département de médecine 221 false 14 Groupe Roosnek Eddy (hémato-oncologie) 19 Bone marrow transplantation 46 9 6e54da9a-33ac-4230-8ece-550b45f6f1b4 Article (Published version) Private Cotrimoxazole.pdf 93030 application/pdf closedAccess Faculté de médecine / Section de médecine clinique / Département de médecine

Title	Published in	Access level	OA Policy	Year	Views	Downloads

Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal	Bone marrow transplantation			2011	607	0

Archive ouverte UNIGE

Fontanet, Aline